Considering the possibilities: New method looks at nearly every mutation in a single gene to identify those driving cancer
Using technologies previously developed at the Broad, researchers have analyzed nearly all genetic variants in the oncogene MAPK1/ERK2, revealing insights that could inform treatment.
October 18, 2016

Credit: Image by Lauren Solomon, Broad Communications.
Using technologies developed previously at the Broad, researchers created a library of nearly every possible mutation in the oncogene <i>MAPK1</i>/ERK2, then systematically tested the function of each mutation.